DSOL (Drug Free Solution) Research & Development: $0.03 Mil (TTM As of Feb. 2014)


What is Drug Free Solution Research & Development?

Drug Free Solution DSOL Research & Development is $0.03 Mil as of Feb. 2014.

Research & Development is the aggregate amount of research and development expenses during the year. Drug Free Solution's Research & Development for the three months ended in Feb. 2014 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2014 was $0.03 Mil.

Drug Free Solution  (OTCPK:DSOL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Drug Free Solution Research & Development Related Terms

Drug Free Solution Research & Development Historical Data

* Premium members only.

The historical data trend for Drug Free Solution's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drug Free Solution Research & Development Chart

Drug Free Solution Annual Data
Trend May12 May13
Research & Development
0.00 0.00

Drug Free Solution Quarterly Data
Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.03 0.00

Drug Free Solution Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.03 Mil mean?
Drug Free Solution (DSOL) has a Research & Development of $0.03 Mil as of Feb. 2014. Research and development expense is the total cost for research and development activities. View historical data on Drug Free Solution and its competitors.
Is Drug Free Solution's Research & Development too high?
Drug Free Solution's current Research & Development is $0.03 Mil.
How does Drug Free Solution's Research & Development compare to USEL and ZZLL?
Drug Free Solution's Research & Development of $0.03 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Drug Free Solution and its competitors. Drug Free Solution's current Research & Development is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drug Free Solution stock overvalued right now?
Drug Free Solution (DSOL) has a current Research & Development of $0.03 Mil. The current Research & Development is $0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Drug Free Solution (DSOL), the current Research & Development is $0.03 Mil as of Feb. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drug Free Solution Business Description

Address 2211 Michelson Drive, Irvine, CA, USA, 92612
Drug Free Solution Inc is a United States based holding company that owns and operates various subsidiaries in the healthcare industry. It is focused on acquiring healthcare operations that focus on Home Healthcare, Developmental Disabilities, Hospice Care, Skilled Nursing, Residential Rehabilitation, Home & Community Based Services.